WO2009072334A1 - 製剤用核粒子 - Google Patents
製剤用核粒子 Download PDFInfo
- Publication number
- WO2009072334A1 WO2009072334A1 PCT/JP2008/066159 JP2008066159W WO2009072334A1 WO 2009072334 A1 WO2009072334 A1 WO 2009072334A1 JP 2008066159 W JP2008066159 W JP 2008066159W WO 2009072334 A1 WO2009072334 A1 WO 2009072334A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- core particle
- pharmaceutical preparation
- inorganic material
- active ingredient
- pharmaceutically active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/745,851 US9149434B2 (en) | 2007-12-03 | 2008-09-08 | Core particle for pharmaceutical preparation |
EP08857578.2A EP2223702B1 (en) | 2007-12-03 | 2008-09-08 | Core particle for pharmaceutical preparation |
JP2009544605A JPWO2009072334A1 (ja) | 2007-12-03 | 2008-09-08 | 製剤用核粒子 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007-312894 | 2007-12-03 | ||
JP2007312894 | 2007-12-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009072334A1 true WO2009072334A1 (ja) | 2009-06-11 |
Family
ID=40717516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/066159 WO2009072334A1 (ja) | 2007-12-03 | 2008-09-08 | 製剤用核粒子 |
Country Status (4)
Country | Link |
---|---|
US (1) | US9149434B2 (ja) |
EP (1) | EP2223702B1 (ja) |
JP (2) | JPWO2009072334A1 (ja) |
WO (1) | WO2009072334A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011026307A (ja) * | 2009-06-28 | 2011-02-10 | Tomita Pharmaceutical Co Ltd | 製剤用核粒子 |
JP2012508784A (ja) * | 2008-11-14 | 2012-04-12 | デブルジャ・ゼ・タソシエ・ファルマ | γ−ヒドロキシ酪酸に基づく新規の組成物 |
WO2012091040A1 (ja) * | 2010-12-27 | 2012-07-05 | 富田製薬株式会社 | 製剤用崩壊型核粒子 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7053092B2 (en) | 2001-01-29 | 2006-05-30 | Otsuka Pharmaceutical Co., Ltd. | 5-HT1a receptor subtype agonist |
AR033485A1 (es) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
US8703772B2 (en) | 2001-09-25 | 2014-04-22 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
US10835495B2 (en) | 2012-11-14 | 2020-11-17 | W. R. Grace & Co.-Conn. | Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same |
EP3860572A1 (en) * | 2018-10-04 | 2021-08-11 | Chemische Fabrik Budenheim KG | Spherical beads for use in producing pharmaceutically active pellets |
EP3892262A1 (en) | 2020-04-06 | 2021-10-13 | Chemische Fabrik Budenheim KG | Beads comprising a buffer system |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0249728A (ja) * | 1988-05-30 | 1990-02-20 | Zeria Pharmaceut Co Ltd | ジヒドロピリジン化合物の製剤組成物 |
JPH02258719A (ja) * | 1989-03-30 | 1990-10-19 | Taisho Pharmaceut Co Ltd | 粒剤の製造方法 |
JPH0549901A (ja) * | 1991-08-21 | 1993-03-02 | Powrex:Kk | 造粒方法 |
JP2003137771A (ja) * | 2001-10-30 | 2003-05-14 | Nichiko Pharmaceutical Co Ltd | 難溶性薬物用医薬製剤 |
WO2006023286A2 (en) * | 2004-08-19 | 2006-03-02 | Alza Corporation | Controlled release nanoparticle active agent formulation dosage forms and methods |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51104026A (en) * | 1975-03-05 | 1976-09-14 | Ishii Hideki | Arufua pp kurorufuenokishiisorakusanechiruganjukokeizaino seizoho |
DE3306250A1 (de) * | 1983-02-23 | 1984-08-23 | Basf Ag, 6700 Ludwigshafen | Sphaerische einkristalle fuer pharmazeutische zwecke |
JPH07106970B2 (ja) * | 1986-06-06 | 1995-11-15 | ライオン株式会社 | 研磨基材 |
JPH03219787A (ja) | 1990-01-24 | 1991-09-27 | Mitsubishi Electric Corp | 多地点間静止画会議システム |
JP2542122B2 (ja) | 1990-04-18 | 1996-10-09 | 旭化成工業株式会社 | 球状核、球形顆粒およびその製造方法 |
JP2820829B2 (ja) * | 1991-03-07 | 1998-11-05 | 武田薬品工業株式会社 | 有核散剤およびその製造方法 |
JP3219787B2 (ja) | 1991-05-28 | 2001-10-15 | フロイント産業株式会社 | 球形粒子の製造方法 |
JP2576927B2 (ja) * | 1992-05-15 | 1997-01-29 | ファイザー製薬株式会社 | 細粒核 |
JPH06192113A (ja) * | 1992-09-25 | 1994-07-12 | Powrex:Kk | 生薬類の造粒方法および固形製剤 |
JP3349535B2 (ja) | 1993-01-12 | 2002-11-25 | フロイント産業株式会社 | 球形顆粒の製造方法 |
JP2700141B2 (ja) * | 1993-09-17 | 1998-01-19 | 富士化学工業株式会社 | リン酸水素カルシウム及びその製法並びにそれを用いた賦形剤 |
JPH09175999A (ja) | 1995-12-22 | 1997-07-08 | Freunt Ind Co Ltd | 球形顆粒およびその製造方法 |
JP3447042B2 (ja) * | 1997-07-23 | 2003-09-16 | フロイント産業株式会社 | 単一物質球形粒の製造方法 |
JP3172695B2 (ja) * | 1997-08-07 | 2001-06-04 | ビーエーエスエフ アクチェンゲゼルシャフト | 球形晶析法による直打用アスコルビン酸原末造粒物、その製造法およびそれを用いた錠剤 |
JPH11322588A (ja) * | 1998-03-20 | 1999-11-24 | Kowa Co | 胃・十二指腸付着性医薬組成物 |
TW499394B (en) * | 1998-04-24 | 2002-08-21 | Fuji Chem Ind Co Ltd | A saccaride-containing cpmposition |
JP4358920B2 (ja) * | 1998-10-07 | 2009-11-04 | 興和創薬株式会社 | エリスリトール含有球形顆粒剤及びその製造方法 |
US6342249B1 (en) * | 1998-12-23 | 2002-01-29 | Alza Corporation | Controlled release liquid active agent formulation dosage forms |
AU1881600A (en) * | 1998-12-23 | 2000-07-31 | Alza Corporation | Dosage forms comprising porous particles |
GB0003782D0 (en) * | 2000-02-17 | 2000-04-05 | Dumex Ltd As | Process |
-
2008
- 2008-09-08 US US12/745,851 patent/US9149434B2/en active Active
- 2008-09-08 EP EP08857578.2A patent/EP2223702B1/en active Active
- 2008-09-08 JP JP2009544605A patent/JPWO2009072334A1/ja active Pending
- 2008-09-08 WO PCT/JP2008/066159 patent/WO2009072334A1/ja active Application Filing
-
2014
- 2014-07-19 JP JP2014148368A patent/JP5757492B2/ja active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0249728A (ja) * | 1988-05-30 | 1990-02-20 | Zeria Pharmaceut Co Ltd | ジヒドロピリジン化合物の製剤組成物 |
JPH02258719A (ja) * | 1989-03-30 | 1990-10-19 | Taisho Pharmaceut Co Ltd | 粒剤の製造方法 |
JPH0549901A (ja) * | 1991-08-21 | 1993-03-02 | Powrex:Kk | 造粒方法 |
JP2003137771A (ja) * | 2001-10-30 | 2003-05-14 | Nichiko Pharmaceutical Co Ltd | 難溶性薬物用医薬製剤 |
WO2006023286A2 (en) * | 2004-08-19 | 2006-03-02 | Alza Corporation | Controlled release nanoparticle active agent formulation dosage forms and methods |
Non-Patent Citations (1)
Title |
---|
See also references of EP2223702A4 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012508784A (ja) * | 2008-11-14 | 2012-04-12 | デブルジャ・ゼ・タソシエ・ファルマ | γ−ヒドロキシ酪酸に基づく新規の組成物 |
JP2011026307A (ja) * | 2009-06-28 | 2011-02-10 | Tomita Pharmaceutical Co Ltd | 製剤用核粒子 |
WO2012091040A1 (ja) * | 2010-12-27 | 2012-07-05 | 富田製薬株式会社 | 製剤用崩壊型核粒子 |
JP5578534B2 (ja) * | 2010-12-27 | 2014-08-27 | 富田製薬株式会社 | 製剤用崩壊型核粒子 |
JP2014169318A (ja) * | 2010-12-27 | 2014-09-18 | Tomita Pharmaceutical Co Ltd | 製剤用崩壊型核粒子 |
Also Published As
Publication number | Publication date |
---|---|
EP2223702A1 (en) | 2010-09-01 |
JP5757492B2 (ja) | 2015-07-29 |
US20100260856A1 (en) | 2010-10-14 |
EP2223702A4 (en) | 2013-10-02 |
JPWO2009072334A1 (ja) | 2011-04-21 |
US9149434B2 (en) | 2015-10-06 |
EP2223702B1 (en) | 2019-05-08 |
JP2014196361A (ja) | 2014-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009072334A1 (ja) | 製剤用核粒子 | |
WO2007109057A3 (en) | Solid dosage form containing a taste masked active agent | |
WO2009061607A3 (en) | Water-immiscible materials as vehicles for drug delivery | |
WO2008149440A1 (ja) | 速溶性及び可撓性を有するフィルム製剤 | |
NZ778023A (en) | Colonic drug delivery formulation | |
WO2007133583A3 (en) | Zero-order modified release solid dosage forms | |
WO2007095600A3 (en) | Disintegrable oral films | |
WO2007047948A3 (en) | Intranasal administration of rapid acting insulin | |
UA100403C2 (en) | Capsule formulation | |
WO2012054831A3 (en) | Ready to use ketorolac formulations | |
WO2006102446A3 (en) | Multi-particulate, modified-released colonic composition | |
WO2007008752A3 (en) | Sustained release pharmaceutical compositions for highly water soluble drugs | |
WO2011039768A3 (en) | Pharmaceutical compositions for reducing alcohol-induced dose dumping | |
WO2007016388A3 (en) | Liquid formulations for controlled delivery of benzisoxazole derivatives | |
WO2007043057A3 (en) | Compositions for nasal delivery | |
WO2007143155A3 (en) | Sustained release pharmaceutical dosage form containing phenylephrine | |
WO2010081824A3 (en) | Active coating of pharmaceutical dosage forms | |
CY1107576T1 (el) | Ταχεια αποδεσμευση των υδατοδιαλυτων φαρμακευτικων ουσιων | |
WO2006060681A3 (en) | Pharmaceutical composition containing an anti-nucleating agent | |
WO2009106824A3 (en) | Pharmaceutical formulations with a taste masking coating | |
WO2009034431A3 (en) | Controlled-release dosage forms for varenicline | |
WO2007084212A3 (en) | Biologically active composition comprising ethylcellulose | |
WO2006138571A3 (en) | Composition and methods for treating complications associated with ingestion of a medicinal, chemical or biological substance | |
WO2008081829A1 (ja) | 難水溶性薬物の溶解性維持用アミノアルキルメタアクリレートコポリマーe | |
WO2007086911A3 (en) | Stable nanoparticle formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08857578 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2009544605 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12745851 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008857578 Country of ref document: EP |